Translating AI-Driven Neoantigen Discovery Into Clinical Reality: Lessons From Evaxion’s Latest Trial Readouts

• Evaluating how AI-based prediction influences trial design, patient selection, and antigen prioritization strategies

• Addressing logistical and operational learnings from moving an AI-predicted vaccine into the clinic

• Outlining next steps to scale trials and build confidence in AI-enabled cancer vaccine platforms

Speakers: